📰 Amneal Pharms News
Amneal Pharms News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amneal Pharms. Real-time updates on events, politics, business and more.
April 26, 2024
The Federal Circuit handed down an opinion last week that invalidated several asserted claims and found infringement under 35 U.S.C. § 271(e)(2) of the claims, while refusing to modify...
April 2, 2024
Calls for Removal of Device Patents Listed in the Orange Book Continue. FTC and Congressional action scrutinizing allegedly “improper” Orange Book listings continued apace in the first...
January 24, 2024
Global Nadolol Market Analysis (2019 - 2030)
January 24, 2024
Global Doxepin Hydrochloride Market Analysis (2019 - 2030)
November 15, 2023
Case Name: CMP Development, LLC v. Amneal Pharms. LLC, Civ No. 21-549 (MN), 2023 WL 6387792 (D. Del. Sept. 29, 2023) (Noreika, J.).
August 19, 2023
Global Nadolol Market Analysis (2019 - 2030)
August 19, 2023
Global Doxepin Hydrochloride Market Analysis (2019 - 2030)
March 20, 2023
By Craig R. Smith and Kevin M. Eckert BridgeTower Media Newswires “Silence is of different kinds, and breathes different meanings.” — “Villette” by Charlotte Brontë *** Silence is not disclosure, except when it is. This year, the Federal Circuit decided multiple patent cases addressing negative claim limitations and the meaning of silence. The decisions provide ...
February 23, 2023
Silence is not disclosure, except when it is. Last year, the Federal Circuit decided multiple patent cases addressing negative claim limitations and the meaning of silence. The decisions provide different standards for determining how much disclosure is required to support a negative claim limitation in a patent specification versus in the prior art.
May 17, 2022
Cognizant Technology’s Privilege Waiver - On February 1, 2022, the District of New Jersey ordered a company to produce internal investigation materials to two former executives indi...